• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氢青蒿素与哌喹治疗恶性疟的随机对照研究

[Randomised comparison on the treatment of falciparum malaria with dihydroartemisinin and piperaquine].

作者信息

Guo X B

机构信息

Sanay Tropical Medicine Institute, Guangzhou College of Traditional Chinese Medicine.

出版信息

Zhonghua Yi Xue Za Zhi. 1993 Oct;73(10):602-4, 638.

PMID:8313183
Abstract

In 1988, 50 cases each of falciparum malaria were treated by dihydroartemisin (360 mg in 5 days and 480 mg in 7 days respectively), and compared randomly with piperaquine phosphate group. The results showed that the plasmodium of falciparal malaria in Dong Fang County, Hainan province, is much more resistant to piperaquine phosphate, in the 51 cases treated by piperaquine, 33.3% were sensitive, 19.0% were RI, 21.6% were RII, and 25.5% were RIII. The effect of dihydroartemisinin (both 5 days and 7 days therapy) were obviously better than that of pipera quine, fever subsidence time and parasite clearance time were similar and parasite recrudescence rate showed no obvious difference in these two groups too.

摘要

1988年,分别用双氢青蒿素(5天疗程360毫克、7天疗程480毫克)治疗恶性疟各50例,并与磷酸哌喹组进行随机对照。结果表明,海南省东方县恶性疟原虫对磷酸哌喹耐药性较强,在51例用磷酸哌喹治疗的患者中,敏感率为33.3%,RI为19.0%,RII为21.6%,RIII为25.5%。双氢青蒿素(5天和7天疗程)疗效明显优于磷酸哌喹,两组退热时间和原虫转阴时间相近,原虫复燃率也无明显差异。

相似文献

1
[Randomised comparison on the treatment of falciparum malaria with dihydroartemisinin and piperaquine].双氢青蒿素与哌喹治疗恶性疟的随机对照研究
Zhonghua Yi Xue Za Zhi. 1993 Oct;73(10):602-4, 638.
2
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.双氢青蒿素-哌喹与青蒿琥酯-甲氟喹治疗恶性疟的疗效与效果:一项开放标签随机对照研究
Lancet. 2006 Jun 24;367(9528):2075-85. doi: 10.1016/S0140-6736(06)68931-9.
3
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.双氢青蒿素-哌喹治疗越南耐多药恶性疟原虫疟疾:随机临床试验
Lancet. 2004 Jan 3;363(9402):18-22. doi: 10.1016/s0140-6736(03)15163-x.
4
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.柬埔寨三突变(包括kelch13 C580Y)导致双氢青蒿素-哌喹耐药:一项观察性队列研究。
Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.
5
[Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China].双氢青蒿素哌喹与蒿甲醚本芴醇治疗中国海南无并发症恶性疟的疗效
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008 Feb 28;26(1):50-2.
6
[Comparative study of artemisinin suppositories and piperaquine phosphate in the treatment of falciparum malaria].青蒿素栓剂与磷酸哌喹治疗恶性疟的对比研究
Zhong Xi Yi Jie He Za Zhi. 1989 Aug;9(8):475-7, 453.
7
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.用于印度尼西亚巴布亚地区抗药性恶性疟和间日疟的两种固定剂量青蒿素联合疗法:一项开放标签随机对照研究
Lancet. 2007 Mar 3;369(9563):757-765. doi: 10.1016/S0140-6736(07)60160-3.
8
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam.越南双氢青蒿素/哌喹治疗恶性疟原虫疟疾的治疗失败情况
Emerg Infect Dis. 2017 Apr;23(4):715-717. doi: 10.3201/eid2304.161872.
9
[Efficacy of compound dihydroartemisinin/piperaquine in treatment of uncomplicated falciparum malaria in Myanmar].复方双氢青蒿素/哌喹治疗缅甸无并发症恶性疟的疗效
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2011 Aug;29(4):296-8.
10
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam.越南南部恶性疟原虫对双氢青蒿素-哌喹敏感性的迅速下降。
Malar J. 2017 Jan 13;16(1):27. doi: 10.1186/s12936-017-1680-8.

引用本文的文献

1
Multidisciplinary Investigations of Sustained Malaria Transmission in the Greater Mekong Subregion.大湄公河次区域持续性疟疾传播的多学科研究。
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):138-151. doi: 10.4269/ajtmh.21-1267.
2
Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China-Myanmar, Thailand-Myanmar, and Thailand-Cambodia borders.评价来自中缅、泰缅和泰柬边境地区恶性疟原虫分离株的双氢青蒿素-哌喹耐药候选标志物。
Parasit Vectors. 2022 Apr 12;15(1):130. doi: 10.1186/s13071-022-05239-1.
3
Susceptibility of Isolates from the China-Myanmar Border Area to Piperaquine and Association with Candidate Markers.
中缅边境地区分离株对哌喹的敏感性及其与候选标志物的关联
Antimicrob Agents Chemother. 2023 May 1;65(5). doi: 10.1128/AAC.02305-20. Epub 2021 Mar 8.
4
Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites.中缅边境地区疟原虫分离株耐药性的纵向监测显示多药耐药寄生虫持续循环。
Int J Parasitol Drugs Drug Resist. 2018 Aug;8(2):320-328. doi: 10.1016/j.ijpddr.2018.05.003. Epub 2018 May 22.
5
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.柬埔寨西部恶性疟原虫对青蒿素和哌喹多重耐药的证据:双氢青蒿素 - 哌喹开放标签多中心临床评估
Antimicrob Agents Chemother. 2015 Aug;59(8):4719-26. doi: 10.1128/AAC.00835-15. Epub 2015 May 26.
6
Development of antimalarial drugs and their application in China: a historical review.抗疟药物的发展及其在中国的应用:历史回顾。
Infect Dis Poverty. 2014 Mar 20;3(1):9. doi: 10.1186/2049-9957-3-9.
7
Effects of a high-fat meal on the relative oral bioavailability of piperaquine.高脂餐对哌喹相对口服生物利用度的影响。
Antimicrob Agents Chemother. 2005 Jun;49(6):2407-11. doi: 10.1128/AAC.49.6.2407-2411.2005.
8
Piperaquine: a resurgent antimalarial drug.哌喹:一种重新兴起的抗疟药物。
Drugs. 2005;65(1):75-87. doi: 10.2165/00003495-200565010-00004.
9
Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.磷酸哌喹在非复杂性恶性疟或间日疟成人及儿童中的群体药代动力学。
Br J Clin Pharmacol. 2004 Mar;57(3):253-62. doi: 10.1046/j.1365-2125.2003.02004.x.
10
In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon.咯萘啶及其他4-氨基喹啉对喀麦隆恶性疟原虫临床分离株的体外活性
Antimicrob Agents Chemother. 2003 Apr;47(4):1391-4. doi: 10.1128/AAC.47.4.1391-1394.2003.